Latest Insider Transactions at Bausch & Lomb Corp (BLCO)
This section provides a real-time view of insider transactions for Bausch & Lomb Corp (BLCO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Bausch & Lomb Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Bausch & Lomb Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,276
+5.62%
|
$25,520
$20.07 P/Share
|
|
Jun 30
2023
|
Richard U De Schutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,339
+4.53%
|
$26,780
$20.07 P/Share
|
|
Jun 30
2023
|
Nathalie D. Bernier Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+3.78%
|
$24,900
$20.07 P/Share
|
|
Jun 14
2023
|
Luc Bonnefoy President,Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
5,361
+10.7%
|
-
|
|
May 04
2023
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,857
+38.97%
|
-
|
|
May 04
2023
|
Thomas W. Ross Sr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,857
+33.64%
|
-
|
|
May 04
2023
|
Andrew C. Von Eschenbach Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,857
+33.64%
|
-
|
|
May 04
2023
|
Sarah B Kavanagh Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,857
+40.79%
|
-
|
|
May 04
2023
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,857
+32.57%
|
-
|
|
May 04
2023
|
Gaoxiang Hu Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,857
+32.99%
|
-
|
|
May 04
2023
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,857
+32.99%
|
-
|
|
May 04
2023
|
Nathalie D. Bernier Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,857
+29.69%
|
-
|
|
May 04
2023
|
Richard U De Schutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,857
+32.34%
|
-
|
|
Apr 24
2023
|
A Robert D Bailey EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
120,500
+50.0%
|
-
|
|
Apr 24
2023
|
Andrew J. Stewart Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,150
+50.0%
|
-
|
|
Apr 24
2023
|
Nathalie D. Bernier Director |
SELL
Payment of exercise price or tax liability
|
Direct |
227
-1.27%
|
$3,859
$17.12 P/Share
|
|
Apr 24
2023
|
Russel C Robertson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
6,692
-47.9%
|
$113,764
$17.12 P/Share
|
|
Apr 24
2023
|
Sarah B Kavanagh Director |
SELL
Payment of exercise price or tax liability
|
Direct |
6,692
-53.54%
|
$113,764
$17.12 P/Share
|
|
Mar 31
2023
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,471
+9.53%
|
$25,007
$17.41 P/Share
|
|
Mar 31
2023
|
Richard U De Schutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,543
+9.9%
|
$26,231
$17.41 P/Share
|
|
Mar 31
2023
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,256
+8.37%
|
$21,352
$17.41 P/Share
|
|
Mar 31
2023
|
Nathalie D. Bernier Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,435
+7.45%
|
$24,395
$17.41 P/Share
|
|
Mar 01
2023
|
Frederick Munsch SVP, Controller and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
7,529
+15.43%
|
-
|
|
Mar 01
2023
|
Joseph F Gordon Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,258
+14.47%
|
-
|
|
Mar 01
2023
|
Yehia Hashad EVP of R&D and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
17,715
+16.85%
|
-
|
|
Mar 01
2023
|
Christina Ackermann Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,344
+16.19%
|
-
|
|
Mar 01
2023
|
Sam Eldessouky EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
42,517
+17.35%
|
-
|
|
Dec 30
2022
|
Nathalie D. Bernier Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,625
+9.03%
|
$24,375
$15.51 P/Share
|
|
Sep 30
2022
|
Nathalie D. Bernier Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,507
+9.27%
|
$22,605
$15.34 P/Share
|
|
Jul 27
2022
|
Frederick Munsch SVP, Controller and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
11,500
+25.43%
|
-
|
|
Jul 25
2022
|
Yehia Hashad EVP of R&D and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+33.42%
|
-
|
|
Jul 25
2022
|
Joseph F Gordon Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+25.1%
|
-
|
|
Jul 25
2022
|
Sam Eldessouky EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+17.95%
|
-
|
|
Jul 25
2022
|
Christina Ackermann Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+22.83%
|
-
|
|
Jun 30
2022
|
Nathalie D. Bernier Director |
BUY
Grant, award, or other acquisition
|
Direct |
748
+5.34%
|
$11,220
$15.24 P/Share
|
|
Jun 28
2022
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,256
+50.0%
|
-
|
|
Jun 28
2022
|
Gaoxiang Hu Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,256
+50.0%
|
-
|
|
Jun 01
2022
|
Bausch Health Companies Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,550,357
-1.44%
|
$77,356,069
$17.05 P/Share
|
|
May 10
2022
|
Andrew C. Von Eschenbach Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+50.0%
|
-
|
|
May 10
2022
|
Richard U De Schutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+50.0%
|
-
|
|
May 10
2022
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+50.0%
|
-
|
|
May 10
2022
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+50.0%
|
-
|
|
May 10
2022
|
Thomas W. Ross Sr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+50.0%
|
-
|
|
May 10
2022
|
Sarah B Kavanagh Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+50.0%
|
-
|
|
May 10
2022
|
Nathalie D. Bernier Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+50.0%
|
-
|
|
May 10
2022
|
Bausch Health Companies Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
35,000,000
-10.0%
|
$595,000,000
$17.05 P/Share
|
|
May 05
2022
|
Yehia Hashad EVP of R&D and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
34,722
+50.0%
|
-
|
|
May 05
2022
|
Sam Eldessouky EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+50.0%
|
-
|
|
May 05
2022
|
Joseph C Papa CEO & Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
472,222
+50.0%
|
-
|
|
May 05
2022
|
Christina Ackermann Officer |
BUY
Grant, award, or other acquisition
|
Direct |
83,333
+50.0%
|
-
|